Related Experiment Video
Updated: Aug 22, 2025

06:48
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
9.0K
An Attention-Guided CNN Framework for Segmentation and Grading of Glioma Using 3D MRI Scans
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|November 9, 2022
Summary
This study introduces a novel CNN framework for automated glioma grading from 3D MRI scans. The method accurately segments tumors and classifies glioma grades, outperforming existing approaches.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Glioma is a deadly brain tumor requiring timely diagnosis for effective treatment.
- Manual Magnetic Resonance Imaging (MRI) analysis for gliomas is time-consuming and prone to errors.
- Automated diagnosis systems are crucial for efficient clinical management and surgical planning of gliomas.
Purpose of the Study:
- To develop a Convolutional Neural Network (CNN)-based framework for non-invasive glioma grading using 3D MRI scans.
- To improve the accuracy and efficiency of glioma diagnosis and classification.
Main Methods:
- Proposed a novel CNN framework with two architectures: one for tumor segmentation and another for multi-task glioma grading.
- The segmentation network incorporates spatial and channel attention modules.
- The classification network performs multi-task learning for low-grade/high-grade classification, 1p19q codeletion, and Isocitrate Dehydrogenase (IDH) status identification.
Main Results:
- The proposed framework demonstrated superior performance compared to several state-of-the-art methods in glioma grading.
- Experimental results showed high accuracy in tumor segmentation and classification tasks.
- Welch's t-test confirmed the statistical significance of the grading results.
Conclusions:
- The developed CNN framework offers an effective automated solution for non-invasive glioma grading from 3D MRI.
- This approach has the potential to significantly aid clinicians in diagnosing and managing glioma patients.
- The study provides a valuable tool for advancing neuro-oncology research and practice.

